OLD Point Trust & Financial Services N A Has $947,000 Stake in Agilent Technologies, Inc. (NYSE:A)

OLD Point Trust & Financial Services N A lowered its holdings in Agilent Technologies, Inc. (NYSE:A) by 4.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,051 shares of the medical research company’s stock after selling 365 shares during the quarter. OLD Point Trust & Financial Services N A’s holdings in Agilent Technologies were worth $947,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in A. CKW Financial Group increased its holdings in shares of Agilent Technologies by 114.9% in the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares in the last quarter. Global X Japan Co. Ltd. increased its stake in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after buying an additional 116 shares during the period. Hanson & Doremus Investment Management raised its position in shares of Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after acquiring an additional 105 shares during the last quarter. OFI Invest Asset Management acquired a new position in shares of Agilent Technologies during the fourth quarter valued at $37,000. Finally, RPg Family Wealth Advisory LLC bought a new position in Agilent Technologies in the third quarter valued at about $38,000.

Insider Activity at Agilent Technologies

In related news, VP Rodney Gonsalves sold 1,908 shares of the company’s stock in a transaction on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the sale, the vice president now directly owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This represents a 4.60 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Price Performance

Shares of A opened at $122.27 on Thursday. The company has a 50 day moving average of $137.41 and a 200-day moving average of $137.57. Agilent Technologies, Inc. has a twelve month low of $117.17 and a twelve month high of $155.35. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock has a market capitalization of $34.86 billion, a P/E ratio of 28.11, a P/E/G ratio of 3.45 and a beta of 1.11.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The company had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be issued a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.81%. Agilent Technologies’s dividend payout ratio is presently 22.76%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on A shares. Wells Fargo & Company lowered their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Citigroup lifted their target price on shares of Agilent Technologies to $165.00 and gave the stock a “buy” rating in a report on Thursday, December 19th. Robert W. Baird cut their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. JPMorgan Chase & Co. decreased their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research note on Tuesday, November 26th. Finally, Sanford C. Bernstein cut their target price on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating on the stock in a research note on Tuesday, November 26th. Seven equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.